The New Medications for Type 2 Diabetes: Expert Guidance and Key Questions Every Patient Should Ask
- Health Communicator
- Jun 22
- 5 min read
Updated: Jul 9
Introduction
This article is based on recommendations and analysis from the 2024 publication “Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Clinical Guideline From the American College of Physicians”, published in the Annals of Internal Medicine. The guideline was developed by the Clinical Guidelines Committee (CGC) of the American College of Physicians (ACP)—a multidisciplinary team of 14 experts, primarily internal medicine specialists, along with representatives from the general public, clinical pharmacologists, and epidemiologists. All recommendations are grounded in a systematic review and network meta-analysis of randomized controlled trials that evaluated the effectiveness, safety, patient preferences, and economic aspects of newer medications for treating type 2 diabetes in adults.
What the Experts Say
This article presents expert opinions derived from ACP’s clinical guideline, based on the most up-to-date scientific evidence for the treatment of adults with type 2 diabetes (T2D) using newer drug therapies. Each section features a guiding question that can help patients, their families, and healthcare providers make informed decisions. We’ve also included explanations in plain language to help all readers better understand the recommendations.
